Brighton Jones’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Brighton Jones's NVO Position: Q3 2026 in Review
Brighton Jones reduced its Novo Nordisk (NVO) stake by 7.2% in Q3 2026, selling an estimated $24.1K and leaving 6,722 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #1135.
Brighton Jones first reported a position in NVO in Q3 2018 and has held it in 20 quarters since. The position peaked at $2.08M in Q2 2024. 1,093 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Brighton Jones held 6,722 shares of Novo Nordisk worth $255K as of Q3 2026.
- Brighton Jones sold 523 Novo Nordisk shares in Q3 2026, an estimated $24.1K.
- Novo Nordisk made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1135 holding.
- Brighton Jones first reported a position in Novo Nordisk in Q3 2018 and has held it in 20 quarters since.
- Brighton Jones's Novo Nordisk position peaked at $2.08M in Q2 2024.
- 1,093 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.